Physician profile
Matthew B Bloom
NPI 1477631844
$41,927.29
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,835 · 2020: $26.65 · 2021: $63.82 · 2022: $5,373 · 2023: $23K · 2024: $3,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,200 · Travel and Lodging: $2,736 · Education: $2,250 · Food and Beverage: $1,227 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,200.00 |
| Travel and Lodging | $2,735.85 |
| Education | $2,250.00 |
| Food and Beverage | $1,227.40 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,480.26 | 2022-2023 | Spyglass Discover, Wavewriter Alpha Prime 16, Spyglass |
| Intuitive Surgical, INC. | $8,827.45 | 2022-2024 | Da Vinci Surgical System, Da Vinci Sp |
| Allergan, INC. | $8,205.32 | 2019-2021 | |
| Heron Therapeutics, INC. | $1,690.30 | 2019 | |
| Spr Therapeutics, INC | $279.11 | 2024 | Sprint Pns System |
| Medtronic, INC. | $169.78 | 2021-2024 | Signia |
| Mallinckrodt Hospital Products INC. | $128.14 | 2024 | Terlivaz |
| Davol INC. | $84.75 | 2024 | Phasix Mesh |
| Kls-Martin L.P. | $26.51 | 2022 | |
| Revance Therapeutics, INC. | $22.76 | 2024 | Daxxify |
| Cook Medical LLC | $12.91 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.